Lower Gastrointestinal Bleeding and Colitis

Chapter 60


Lower Gastrointestinal Bleeding and Colitis




Lower Gastrointestinal Bleeding (LGIB)


Gastrointestinal bleeding (GIB) is a common clinical problem, accounting for ~1% of acute hospital admissions. Most cases require the intensive care unit (ICU). The ICU management goals of all GIB, upper (UGIB) or lower (LGIB), are stabilization of the patient, prompt diagnosis of the etiology of bleeding, and definitive therapy when possible. This chapter provides an overview for recognizing and treating the most common causes of LGIB.


LGIB is intestinal bleeding that occurs from a source distal to the ligament of Treitz. Various terms to describe LGIB include hematochezia, rectal bleeding, and bright red blood per rectum. These terms fail to indicate the acuity or severity of bleeding, localize the bleeding source, and exclude bleeding from beyond the ligament of Treitz. For example, when all cases of suspected acute LGIB are thoroughly investigated, 10% to 15% are actually bleeding from upper gastrointestinal sources.


Approximately 80% of all patients with acute LGIB cease bleeding spontaneously, but a quarter of these individuals will have recurrent bleeding. The overall mortality of 10% to 15% in LGIB is increased in patients with recurrent or persistent bleeding. In up to 8% to 12% of suspected cases of LGIB, no bleeding source is identified.



History and Causes


Initial assessment of patients with all GIB should begin with the measurement of vital signs including heart rate and blood pressure (Figure 60.1). Concomitantly with resuscitation, a directed history and a focused physical examination relevant to LGIB should be performed.



The diverse causes of acute LGIB (Table 60.1) can be broadly divided among anatomic, vascular, inflammatory, and neoplastic etiologies. In patients younger than 50 years of age, hemorrhoids are the most common cause, whereas in older patients, diverticulosis and angiodysplasia (arteriovenous malformations) are most frequent. Rectal pain may indicate an anal fissure or hemorrhoids. Abdominal pain may indicate inflammatory bowel disease, ischemia of small or large bowel, or infectious colitis. Painless LGIB, especially in an elderly patient, should increase suspicion of diverticulosis or angiodysplasia. Pain exacerbated with meals can suggest chronic mesenteric ischemia, whereas pain exacerbated by defecation suggests an anal fissure.



The characteristics and color of the patient’s stool in acute LGIB also provide clues about the site of bleeding. Blood from the left side of the colon is typically bright red, whereas blood from the right colon is darker and mixed with stool. Blood on the outside of well-formed stool likely represents an anal canal or rectosigmoid lesion such as hemorrhoids or fissures. A change in bowel habits or stool caliber suggests neoplastic causes. If the patient has bloody diarrhea, consider inflammatory bowel disease or infectious colitis. Although hematochezia, the passage of bright red blood or blood clots per rectum, usually indicates an LGIB source, patients with massive UGIB may also present with hematochezia due to rapid transit of blood through the colon. Hematochezia, in combination with hemodynamic instability, should always raise the possibility of a UGIB. Similarly, LGIB from the distal small bowel or proximal colon can present as melena, or black, tarry stools, a finding typically associated with UGIB and thus an absolute diagnosis of the exact site or etiology of bleeding cannot be made based on the color and characteristics of stool.




Management


Patients with LGIB should be admitted to the ICU if they meet appropriate clinical criteria of severity or concomitant disease (Table 60.2). Appropriate resuscitation efforts should be initiated, including large bore intravenous line placements, isotonic intravenous fluid infusions, and red blood cell transfusions. The target hemoglobin level depends on the patient’s age and comorbid conditions such as coronary artery disease, emphysema, and chronic kidney disease. For an elderly patient with significant comorbidities, the hemoglobin level should be maintained at 10 g/dL. If a patient has a coagulopathy (International Normalized Ratio [INR] > 1.5) or thrombocytopenia (platelets < 50,000/μL), these should be quickly addressed with transfusions of fresh frozen plasma and platelets, respectively. Vitamin K should be given to patients on warfarin in the setting of active GIB. Early in the management of these patients, a nasogastric lavage should be attempted at bedside to evaluate for a possible UGIB. An upper endoscopy should be considered in patients when a UGIB cannot be definitively excluded based on nasogastric lavage or other clinical information. This is particularly important in patients with hematochezia and hemodynamic instability. The surgical and interventional radiology services should be consulted if the patient has massive bleeding (requiring more than 6 units of blood) or develops signs of an acute surgical abdomen.




Diagnostic Evaluation



Colonoscopy


In general, colonoscopy is the initial examination of choice in the evaluation of suspected LGIB, for the advantages of being both diagnostic and potentially therapeutic. Although cleansing of the colon is usually necessary to allow complete mucosal examination, a colonoscopy can also be performed in an unprepared colon, because blood acts as a cathartic. After adequate preparation of the bowel, the diagnostic accuracy of emergent colonoscopy is high (70% to 92%).


For the purpose of colon cleansing, a balanced electrolyte solution is administered orally or via a nasogastric tube at the rate of 240 mL every 15 minutes. This provides reasonably satisfactory cleansing of the bowel in 4 to 6 hours. Once the rectal effluent becomes clear of stool and blood, colonoscopy is performed. There is no evidence that a rapid bowel purge in the setting of active LGIB will reactivate or increase the rate of bleeding. The only absolute contraindications to colonoscopy in the acute setting are hemodynamic instability or suspicion of a perforated viscus.



Radionuclide Imaging


If the patient continues to bleed but remains hemodynamically stable, a radionuclide scan may help localize the site of hemorrhage. Radionuclide scans can detect bleeding rates as low as 0.05 to 0.1 mL/min. Two types of radionuclide scans are currently available to detect GIB: the technetium (99mTc) sulfur colloid scan and the 99mTc pertechnetate-labeled autologous red blood cell scan. Sulfur colloid has a short half-life and is rapidly cleared from the circulation, so a diagnostic scan requires active bleeding at the time of the scan. In contrast, in patients who undergo the 99 mTc pertechnetate-labeled red cell scan, images are obtained during the first 30 minutes after injection, and then every few hours for up to 24 hours, hence providing further opportunities for identification of intermittent bleeding.


The major disadvantage of radionuclide scans is erroneous localization of the site of bleeding, which can occur in up to 25% of cases. In addition, these tests are purely diagnostic and do not have the potential for therapeutic intervention. Radionuclide imaging is most helpful in assessing if patients are bleeding vigorously enough to permit visualization of the site by angiography.

< div class='tao-gold-member'>

Jul 7, 2016 | Posted by in CRITICAL CARE | Comments Off on Lower Gastrointestinal Bleeding and Colitis

Full access? Get Clinical Tree

Get Clinical Tree app for offline access